Aplagon is a clinical stage biopharmaceutical company developing first-in-class therapeutics for thromboinflammatory diseases, including thrombotic and vascular occlusion related cardiovascular diseases
Aplagon is a clinical stage biopharmaceutical company developing first-in-class therapeutics for thromboinflammatory diseases, including thrombotic and vascular occlusion related cardiovascular diseases.